In HepG2 hepatoma cells and liver tissues in high-fat-fed mice, berberine attenuated triglyceride accumulation by activating AMPK and in turn decreased the expression of SREBP-1c and stearyl-coenzyme A desaturase 1 (SCD1) [207]. Here, SREBF1 is linked to hepatocellular carcinoma.